Featured Content
Johnson & Johnson Innovation joined in the $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.
Johnson & Johnson Innovation joined in the $60.75 million series A funding round for SonoThera, a biotech genetic therapy company.